...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Announces Corporate Update Conference Call ... Bear
Document (Journal) page 200 and 201: Entitled
CARDIOVASCULAR AND RENAL PROTECTION-EFFECTS OF SGLT2INHIBITORS AND GLP-1RECEPTOR AGONISTS IN PEOPLE WITH CKD ANDTYPE2DIABETES  
 
EFFECTS OF THE BET-INHIBITOR APABETALONE ONCARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2DIABETES MELLITUS AND ACUTE CORONARY SYNDROME,ACCORDING TO PRESENCE OR ABSENCE OF CHRONICKIDNEY DISEASE. A BETONMACE TRIAL REPORT. 
 
Koo
Share
New Message
Please login to post a reply